Graham Dixon
Chief Tech/Sci/R&D Officer en MITHRA PHARMACEUTICALS S.A. .
Origen de la red de primer grado Graham Dixon.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 63 | |
| Public Company | Biotechnology | 30 | |
| Public Company | Pharmaceuticals: Major | 28 | |
20
| Public Company | Biotechnology | 20 |
InteRNA Technologies BV
 InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands.
9
| Holding Company | Biotechnology | 9 |
| Public Company | Pharmaceuticals: Major | 8 | |
Zeneca Garden Care
 Zeneca Garden Care Pharmaceuticals: OtherHealth Technology Part of AstraZeneca PLC, Zeneca Garden Care is a British company that develops and manufactures pharmaceutical products, agrochemicals, and specialty chemicals. The private company is based in Macclesfield, UK. Zeneca Garden Care was acquired by Zeneca Group Plc on January 01, 1995 for $84.16 million.
5
| Subsidiary | Pharmaceuticals: Other | 5 |
HepaRegeniX GmbH
 HepaRegeniX GmbH Miscellaneous Commercial ServicesCommercial Services HepaRegeniX GmbH engages in the development of treatment for acute and chronic liver diseases. It focuses on Mitogen-Activated Protein Kinase 4, which unlocks the regenerative capacity of hepatocytes even in severely diseased livers. The company was founded in by Wolfgang Albrecht in 2017 and is headquartered in Tuebingen, Germany.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Apaxen SA
 Apaxen SA BiotechnologyHealth Technology Apaxen SA is a privately-held biotechnology company that was founded in 2018 and is based in an undisclosed location. The Belgian company has raised €5.4 million in equity and grant funding since its A round in 2019. Apaxen is focused on developing a pipeline of NLRP3 inflammasome inhibitors with a novel mechanism of action for the treatment of chronic inflammatory and autoimmune diseases. The company's clinical candidate, MFC-1040, is an orally bioavailable and selective small molecule NLRP3 inflammasome inhibitor that has demonstrated efficacy in multiple animal models of chronic inflammatory disease and pulmonary fibrosis. The company's team combines the experience required for clinical development of its products and is supported by a world-class team of scientific advisors. Apaxen has a pipeline of products at discovery and preclinical stages of development for the treatment of diseases associated with chronic inflammation that depend on NLRP3 inflammasome activation. The company was founded in 2018 by Gael Jalce, Enrico Jose Adolfo Bastianelli, and Bart Wuurman has been the CEO of the company since 2020.
3
| Holding Company | Biotechnology | 3 |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Graham Dixon a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ERICSSON | Telecommunications Equipment | Director/Board Member Director/Board Member | |
| INSMED INCORPORATED | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| SHIRE | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| ABLIVA AB | Pharmaceuticals: Major | Investor Relations Contact Director/Board Member | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Founder Investor Relations Contact Director/Board Member | |
| ACTIVE BIOTECH AB | Biotechnology | Public Communications Contact Director/Board Member Director/Board Member | |
| SMARTPHOTO GROUP NV | Specialty Stores | Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Corporate Officer/Principal Doctorate Degree | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Chief Executive Officer Director of Finance/CFO Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Graduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Graduate Degree Graduate Degree | |
| Chalmers University of Technology | College/University | Graduate Degree Director/Board Member | |
| University of Uppsala | College/University | Graduate Degree Doctorate Degree Corporate Officer/Principal | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| University of Lund | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal Masters Business Admin Doctorate Degree Doctorate Degree Doctorate Degree | |
| University of Leiden | College/University | Doctorate Degree Doctorate Degree | |
| University of Utrecht | College/University | Doctorate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
| Radboud University Nijmegen | College/University | Doctorate Degree Doctorate Degree | |
| Vlerick Leuven Gent Management School | College/University | General Counsel Masters Business Admin | |
| University of Liege | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree Corporate Officer/Principal Masters Business Admin Undergraduate Degree | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Chairman Chairman Corporate Officer/Principal | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | President Director/Board Member Director/Board Member | |
| University of Gothenburg | College/University | Doctorate Degree Graduate Degree | |
| Université Catholique de Louvain | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
AnaMar AB
 AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Officer/Principal | |
| Handelshögskolan i Göteborg | College/University | Masters Business Admin Graduate Degree | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | President Chief Tech/Sci/R&D Officer | |
| IMMUNOVIA AB | Pharmaceuticals: Major | Founder Director/Board Member Investor Relations Contact | |
UCB Pharma SA (Belgium)
 UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology UCB Pharma SA discovers and develops biopharmaceutical products. It is a biopharmaceutical company focuses on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. The company is headquartered in Brussels, Belgium. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| Spiber Technologies AB | Director/Board Member Chairman | ||
BioWin ASBL
 BioWin ASBL Miscellaneous Commercial ServicesCommercial Services BioWin ASBL operates as non-profit organization, with interest in the health biotechnology sector. With its member, the firm provides support for the funding in the research and development of biomarkers, nano medicine, drug delivery system, novel therapies, medical devices, and information technology applied to human health. The company is headquartered in Gosselies, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| University of Antwerp | College/University | Doctorate Degree Undergraduate Degree | |
Uteron Pharma SA
 Uteron Pharma SA Electronic Equipment/InstrumentsElectronic Technology Uteron Pharma SA is engaged in the research and development of controlled release devices. The firms products Levosert and Diafert provide pharmaceutical solutions for women's health. The company was founded by Stijn van Rompay in 2010 and is headquartered in Grâce-Hollogne, Belgium. | Electronic Equipment/Instruments | Founder Director/Board Member Founder | |
Atlas Therapeutics AB
 Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The private company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Chairman | |
ApoEx AB
 ApoEx AB Medical DistributorsDistribution Services ApoEx AB offers products and services to healthcare industry. The firm provides services for dentistry, aesthetic surgery and medical care, animal care, and government. The company was founded by Jens-Leo Hubertus Berlips and John Patrick Berlips in 2010 and is headquartered in Stockholm, Sweden. | Medical Distributors | Director/Board Member Director of Finance/CFO | |
Novalon SA
 Novalon SA Pharmaceuticals: MajorHealth Technology Novalon SA manufactures pharmaceutical products. It focuses on the development of therapeutically equivalent generic products that are complex to develop and manufacture. The firm develops the projects Zoreline and Myring, which are therapeutic equivalents to branded products. The company is headquartered in Liege, Belgium. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
miDIAGNOSTICS NV
 miDIAGNOSTICS NV Miscellaneous Commercial ServicesCommercial Services miDIAGNOSTICS NV develops a computer chip powered portable medical laboratory. The company is headquartered in Leuven, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| A Bioscience Incentive AB | Chairman Chairman Director/Board Member Director/Board Member | ||
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| THERAVET SA | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Theravectys SAS
 Theravectys SAS BiotechnologyHealth Technology Theravectys SAS provides biotechnology research services. It is working on the development of a therapeutic vaccine against HIV. The company was founded on May 17, 2005 and is headquartered in Paris, France. | Biotechnology | Chairman Director/Board Member |
Estadísticas
Internacional
| Suecia | 19 |
| Bélgica | 14 |
| Estados Unidos | 10 |
| Países Bajos | 6 |
| Reino Unido | 3 |
Sectorial
| Health Technology | 20 |
| Consumer Services | 17 |
| Commercial Services | 8 |
| Electronic Technology | 3 |
| Finance | 3 |
Operativa
| Director/Board Member | 633 |
| Corporate Officer/Principal | 195 |
| Chairman | 149 |
| Independent Dir/Board Member | 148 |
| Chief Executive Officer | 102 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Graham Dixon
- Conexiones Empresas
